198 related articles for article (PubMed ID: 1174471)
1. Bio-assay of corticosteroids for topical application.
Spearman RI; Jarrett A
Br J Dermatol; 1975 May; 92(5):581-4. PubMed ID: 1174471
[TBL] [Abstract][Full Text] [Related]
2. Epidermal thinning: evaluation of commercial corticosteroids.
Wrench R
Arch Dermatol Res; 1980; 267(1):7-24. PubMed ID: 7387177
[TBL] [Abstract][Full Text] [Related]
3. The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig.
Winter GD; Wilson L
Br J Dermatol; 1976 May; 94(5):545-50. PubMed ID: 1268065
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacology of dermatocorticoids (2. Continuation)].
Weirich EG
Z Hautkr; 1978 Apr; 53(7):209-16 contd. PubMed ID: 645170
[No Abstract] [Full Text] [Related]
5. The effect of corticosteroids on human epidermal mitotic activity.
Fisher LB; Maibach HI
Arch Dermatol; 1971 Jan; 103(1):39-44. PubMed ID: 4321801
[No Abstract] [Full Text] [Related]
6. Objective measurement of topically applied corticosteroids.
Király K; Soós G
Dermatologica; 1976; 152 Suppl 1():133-7. PubMed ID: 955233
[TBL] [Abstract][Full Text] [Related]
7. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
Weirich EG; Lutz U
Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215
[No Abstract] [Full Text] [Related]
8. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
Coldman MF; Lockerbie L; Laws EA
Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552
[No Abstract] [Full Text] [Related]
9. Bioassay system for formulations of topically applied glucocorticosteroids.
Stoughton RB
Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
[No Abstract] [Full Text] [Related]
10. Corticosteroid-induced inhibition of the biosynthesis of human skin collagen.
Uitto J; Teir H; Mustakallio KK
Biochem Pharmacol; 1972 Aug; 21(16):2161-7. PubMed ID: 4646188
[No Abstract] [Full Text] [Related]
11. The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation.
Ishikawa H; Mori Y; Tsurufuji S
Eur J Pharmacol; 1969 Aug; 7(2):201-5. PubMed ID: 5345995
[No Abstract] [Full Text] [Related]
12. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial.
Smith EB; Gregory JF; Bartruff JK
South Med J; 1973 Mar; 66(3):325-9. PubMed ID: 4570656
[No Abstract] [Full Text] [Related]
13. The interaction of corticosteroids and antimicrobial agents used in topical therapy.
Raab WP
Br J Dermatol; 1971 Jun; 84(6):582-9. PubMed ID: 4326734
[No Abstract] [Full Text] [Related]
14. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids.
Poulsen BJ; Burdick K; Bessler S
Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938
[No Abstract] [Full Text] [Related]
15. Comparative study of the vasoconstrictor activity of halopredone acetate in a modified McKenzie test.
Rampini E; Rastelli A; Cardo P
Eur J Clin Pharmacol; 1978 Dec; 14(5):325-9. PubMed ID: 729625
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the effectiveness of locally administered corticosteroids].
Semrádová V; Horácek J
Cesk Dermatol; 1974 Jul; 49(4):222-6. PubMed ID: 4844681
[No Abstract] [Full Text] [Related]
17. An improved method of assessing topical corticosteroid activity.
Barnes H; Gaylarde PM; Brock AP; Sarkany I
Br J Dermatol; 1975 Oct; 93(4):459-64. PubMed ID: 1201192
[TBL] [Abstract][Full Text] [Related]
18. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels.
Barry BW; Woodford R
Br J Dermatol; 1974 Sep; 91(3):323-38. PubMed ID: 4611447
[No Abstract] [Full Text] [Related]
19. Corticosteroid-induced dermal atrophy in the rat.
Young JM; Yoxall BE; Wagner BM
J Invest Dermatol; 1977 Nov; 69(5):458-62. PubMed ID: 908845
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitory action of glucocorticoids on glucose-6-phosphate dehydrogenase activty. A screening of antipsoriatic effects (author's transl)].
Raab W; Siber H
Arch Dermatol Forsch; 1974 Jun; 249(4):357-66. PubMed ID: 4407433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
